Personalizing Statin Therapy in Patients With HIV

Program Goals

Dyslipidemia in HIV Population

Contemporary ART: More Lipid Neutral

Risk of CVD in HIV

Continuous ART Reduces the Risk of CVD: SMART Study

Assessment of CV Risk in Patients With HIV

Atorvastatin Effects on ASCVD Progression in HIV Infection Reduced Plaque Progression vs Placebo

NLA Recommendations for Managing Dyslipidemia

REPRIEVE Trial: Assess Use of Statins as Primary Prevention of CVD in HIV

Use of Statins in Patients With HIV

Use of Statins With PIs

Effect of Statins on Markers of Immune Activation and Inflammation

Hypertriglyceridemia in HIV

Multidisciplinary Team Approach

Abbreviations

Abbreviations (cont)